Search filters

List of works by Karen L. Reckamp

(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib

scientific article

A 75-year-old man with progressive bronchioalveolar carcinoma

scientific article published in February 2013

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

scientific article

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105

scientific article published on 28 November 2018

A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma

scientific article published in March 2008

A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib

scientific article

A phase I study of bortezomib and temozolomide in patients with advanced solid tumors.

scientific article

A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer

scientific article published on June 2006

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer

scientific article published on 14 February 2011

Akt inhibitors in clinical development for the treatment of cancer

scientific article published on 16 September 2010

An interdisciplinary care approach for integration of palliative care in lung cancer

scientific article published in November 2008

Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations

scientific article published on 12 July 2019

Antiangiogenic agents as second-line therapy for advanced non-small cell lung cancer ⬇️

scientific article published on 03 February 2012

Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480.

scientific article published on 15 September 2011

Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab

scientific article

Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer

scientific article

Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).

scientific article published on October 2011

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer

scientific article

Characterizing and Modulating the Tumor Microenvironment in Renal Cell Carcinoma: Potential Therapeutic Strategies

article

Chemokines as therapeutic targets in renal cell carcinoma

scientific article

City of Hope Cancer Center hematology-oncology fellowship and hematopoietic stem cell transplantation fellowship

scientific article

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer

scientific article published on 15 April 2019

Combination chemotherapy for older adults with advanced non-small-cell lung cancer ⬇️

scientific article published on August 8, 2011

Consistency of a two clinical site sample collection: a proteomics study

scientific article published in September 2010

Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study.

scientific article published on 21 March 2018

Expression of CXCR3 on Mononuclear Cells and CXCR3 Ligands in Patients With Metastatic Renal Cell Carcinoma in Response to Systemic IL-2 Therapy

article

Future of ALK inhibition in non-small-cell lung cancer.

scientific article published on 18 August 2014

Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing.

scientific article published on 14 March 2018

Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines

scientific article

Inflammation and lung carcinogenesis: applying findings in prevention and treatment.

scientific article published on October 2007

Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance

scientific article published on February 2008

Interdisciplinary Palliative Care for Patients With Lung Cancer

scientific article

Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma

scientific article published in March 2006

Intraventricular Chemotherapy for Leptomeningeal Carcinomatosis from Lung Cancer: A Feasible and Beneficial Treatment Option?

scientific article published on 01 May 2013

Is benefit of maintenance therapy for NSCLC best defined by progression-free survival?

scientific article

Long-Term Effect of an Interdisciplinary Supportive Care Intervention for Lung Cancer Survivors After Surgical Procedures

scientific article

Longitudinal changes in function, symptom burden, and quality of life in patients with early-stage lung cancer ⬇️

scientific article published on November 10, 2012

Management of non-small-cell lung cancer in the older adult

scientific article published on 03 February 2011

Molecular origins of lung cancer: prospects for personalized prevention and therapy.

scientific article published in June 2010

Myeloid clusters are associated with a pro-metastatic environment and poor prognosis in smoking-related early stage non-small cell lung cancer

scientific article

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

scientific article (publication date: 9 July 2015)

Non-small cell lung cancer in the elderly: defining treatment options

scientific article published on December 2008

PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells

scientific article published on 20 May 2005

PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.

scientific article

Phase 1b study of motesanib, an oral angiogenesis inhibitor, in combination with carboplatin/paclitaxel and/or panitumumab for the treatment of advanced non-small cell lung cancer

scientific article

Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors.

scientific article

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A

scientific article published in 2022

Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib

scientific article

Phosphatidylinositol-3-Kinase Pathway ⬇️

scientific article published on December 1, 2012

Predictors of finding benefit after lung cancer diagnosis

scientific article published on 20 January 2011

Preparing Cancer Patients and Family Caregivers for Lung Surgery: Development of a Multimedia Self-Management Intervention

scientific article published on 20 August 2016

Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.

scientific article published on July 2005

Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer

scientific article published on 29 May 2015

Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial.

scientific article published in January 2011

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.

scientific article published on 22 January 2016

Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.

scientific article published on 16 July 2015

Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis

scientific article

Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium

scientific article

Targeted therapies for non-small cell lung cancer: an evolving landscape

scientific article published on 22 June 2010

Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.

scientific article

Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells ⬇️

scientific article published on September 14, 2010

The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA

scientific article published on 02 July 2018

The FEN1 E359K germline mutation disrupts the FEN1-WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers.

scientific article

The impact of lung cancer surgery on quality of life trajectories in patients and family caregivers

scientific article published on 30 August 2016

The potential and rationale for COX-2 inhibitors in lung cancer

scientific article

The role of targeting mammalian target of rapamycin in lung cancer

scientific article

Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France

scientific article published on 6 June 2016

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer

scientific article published in June 2005

Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin

scientific article published in February 2008

Paulina is supported by:

About Paulina

Help